Clinical cell-surface targets in metastatic and primary solid cancers
Therapies against cell-surface targets (CSTs) represent an emerging treatment class in solid malignancies. However, high-throughput investigations of CST expression across cancer types have been reliant on data sets of mostly primary tumors, despite therapeutic use most commonly in metastatic diseas...
| 出版年: | JCI Insight |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
American Society for Clinical investigation
2024-09-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1172/jci.insight.183674 |
